Pfizer and BioNTech Granted Favorable CHMP Assessment for Omicron XBB.1.5-adapted COVID-19 Vaccine in the EU
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommendation is grounded in pre-clinical
Read more